BeStock  
Markets › Compare › TXG vs GME

TXG vs GME

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TXG · 10x Genomics$97.74 ▲ 4.53%
GME · GameStop$25.24 ▲ 2.19%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

27243458673889Oct 7, '25Apr 7, '26Oct 5, '26
  • TXG +742.6%
  • GME +3.7%

Head to head

MetricTXGGME
Price$97.74$25.24
Change today▲ 4.53%▲ 2.19%
Market cap$12.73B$12.73B
Return, 3 months+158.4%+13.7%
Return, year to date+499.3%+25.7%
Return, 1 year+673.3%+0.8%
P/E (TTM)-165.716.6
P/B15.42.1
P/E percentile vs own 5y–54th
Dividend yield––
Revenue growth (YoY, latest qtr)–-18.7%
Net profit growth (YoY)–+77.2%
Gross margin–37.9%
Operating margin–13.9%
Net margin–25.2%
Return on equity–15.8%
Analyst target vs. price––
Analyst buy share––
RSI (14)8070
30-day volatility56.6%39.9%
Max drawdown, 1 year-28.0%-35.5%
Trend readStrong uptrendStrong uptrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • TXG is the largest of the group by market value.
  • TXG has returned the most over the past year.
  • TXG carries the lowest trailing P/E.
  • GME has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top